Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US Brand Drug Price Inflation Slowing As Elections Approach

Executive Summary

Wholesalers attribute lower-than-expected earnings in part to moderating price increases for branded drugs and predict the trend will continue into 2017.

You may also be interested in...

Pfizer’s Read Criticizes Rebates Amid Changing Market Dynamics

Pfizer CEO Ian Read suggested it might be time for a new solution that would allow the pharma industry to moderate pricing based on volume without relying on rebates, criticizing a practice he said has become “less helpful” in getting cost effective solutions to patients.

Big Pharma’s Unlikely Price Pledge Leader

Allergan is taking a page from Big Pharma’s strategy two decades ago to fend off efforts at direct price regulation by pledging restraint on price increases. The differences in the pledge – and the image of the pledge maker – are instructive.

EpiPen Price Story Highlights Growing Impact Of Drug Deductibles

Nearly half of employer-sponsored insurance plans surveyed require members to meet a deductible before coverage for a prescription drug is approved.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts